Acasti Pharma Inc. (CVE:ACST – Get Free Report) shares were up 1.8% during trading on Wednesday . The stock traded as high as C$0.58 and last traded at C$0.58. Approximately 2,450 shares traded hands during mid-day trading, a decline of 63% from the average daily volume of 6,576 shares. The stock had previously closed at C$0.57.
Acasti Pharma Stock Performance
The firm’s 50-day moving average price is C$0.58 and its two-hundred day moving average price is C$0.58. The company has a quick ratio of 9.41, a current ratio of 9.74 and a debt-to-equity ratio of 0.52. The firm has a market capitalization of C$25.87 million, a PE ratio of -1.07 and a beta of 1.22.
Acasti Pharma Company Profile
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
See Also
- Five stocks we like better than Acasti Pharma
- Investing in Construction Stocks
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- What Do S&P 500 Stocks Tell Investors About the Market?
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- Profitably Trade Stocks at 52-Week Highs
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
